AI-powered platform that predicts a woman’s risk of developing breast cancer over the next five years using only a standard mammogram. With support from the Breast Cancer Research Foundation (BCRF), Clairity, Inc. is poised to launch the first predictive imaging model in breast cancer. This historic milestone is a major advance in prevention, equity, and personalized care.

The Breast Cancer Research Foundation is dedicated to ending breast cancer by advancing the world’s most promising research. This year, BCRF is the largest private funder of breast cancer research—and metastatic breast cancer research—worldwide and is the highest-rated breast cancer research organization in the country.